More than just a name: "nonalcoholic fatty liver disease (NAFLD)" versus "metabolic associated fatty liver disease (MAFLD)"

Article Sidebar

PDF
Published: May 19, 2023
DOI: https://doi.org/10.18051/UnivMed.2023.v42.119-120 Universa Medicina
Abstract Viewed: 596
PDF Downloaded: 468

Main Article Content

Kathryn Effendi
Department of Pathology, Keio University School of Medicine, Tokyo, Japan
https://orcid.org/0000-0001-7844-1170

Article Details

How to Cite
Effendi, K. (2023). More than just a name: "nonalcoholic fatty liver disease (NAFLD)" versus "metabolic associated fatty liver disease (MAFLD)". Universa Medicina, 42(2), 119–120. https://doi.org/10.18051/UnivMed.2023.v42.119-120
Issue
Vol. 42 No. 2 (2023)
Section
Editorial
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

References

Fouad Y, Waked I, Bollipo S, Gomaa A, Ajlouni Y, Attia D. What’s in a name? Renaming ‘NAFLD’ to ‘MAFLD’. Liver Int 2020;40:1254-61. doi: 10.1111/liv.14478..

Sakamoto M, Tsujikawa H, Effendi K, et al. Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. Pathol Int 2017;67:1-7. doi: 10.1111/pin.12485.

Simon TG, Roelstraete B, Hartjes K, et al. Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality. J Hepatol 2021;75:1034-41. doi: 10.1016/j.jhep.2021.06.034.

Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol 2018;24:3361-73. doi: 10.3748/wjg.v24.i30.3361.

Eslam M, Sanyal AJ, George J; International Consensus Panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 2020;158: 1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312.

García-Compeán D, Jiménez-Rodríguez AR. NAFLD VS MAFLD. The evidence-based debate has come. Time to change? Ann Hepatol 2022;27:100765. doi: 10.1016/j.aohep.2022.100765.

Eslam M, Ratziu V, George J. Yet more evidence that MAFLD is more than a name change. J Hepatol 2021;74:977-9. doi: 10.1016/j.jhep.2020. 12.025.

Singh SP, Anirvan P, Reddy KR, et al. Non-alcoholic fatty liver disease: Not time for an obituary just yet! J Hepatol 2021;74:972-4. doi: 10.1016/j.jhep.2020.10.015.

Duseja A, Taneja S. Changing nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease – not only premature but also confusing. J Clin Exp Hepatol 2021;11:278-9. doi: 10.1016/j.jceh.2020.08. 002.

Ayada I, van Kleef LA, Alferink LJM, Li P, de Knegt RJ, Pan Q. Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: focusing on the non-overlap groups. Liver Int 2022;42:277-87. doi: 10.1111/liv.15139.